Futura Medical is developing a portfolio of products in pain relief and sexual health. Our strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
A highly efficient and proprietary transdermal delivery technology, DermaSys®, delivers more active through the skin. It can be tailored to suit the specific active compound being used and the therapeutic indication. Such targeted delivery offers an optimised profile in terms of dose, onset time, efficacy and duration of effect, as well as an improved safety profile through lower systemic uptake and the reduced risk of side effects.